17126-75-9

Basic information

• Product Name: N,N-BIS(2-HYDROXYETHYL)-3-METHOXYANILINE
• Synonyms: N,N-BIS(2-HYDROXYETHYL)-3-METHOXYANILINE;3-Methoxy-N,N-bis(2-hydroxyethyl)ben-zenamine;m-Methoxy-N,N-bis(-hydroxyethyl)ani-line;2,2'-((3-Methoxyphenyl)azanediyl)diethanol;N,N-Bis(2-hydroxyethyl)-3-Methocyaniline;3-Metghoxy-N,N-Bis(2-Hydroxyethyl)Benzenamine;2-[N-(2-hydroxyethyl)-3-methoxyanilino]ethanol
• CAS NO: 17126-75-9
• Molecular Formula: C₁₁H₁₇NO₃
• Molecular Weight: 211.26
• Mol File: 17126-75-9.mol
• Article Data: 3

Chemical Properties

• Melting Point: 49-50℃
• Boiling Point: 350.94°C (rough estimate)
• Flash Point: 181.3 °C
• Appearance: white crystalline needles or powder
• Density: 1.1240 (rough estimate)
• Vapor Pressure: 2.5E-06mmHg at 25°C
• Refractive Index: 1.5718 (589.3 nm 25℃)
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: N,N-BIS(2-HYDROXYETHYL)-3-METHOXYANILINE(CAS DataBase Reference)
• NIST Chemistry Reference: N,N-BIS(2-HYDROXYETHYL)-3-METHOXYANILINE(17126-75-9)
• EPA Substance Registry System: N,N-BIS(2-HYDROXYETHYL)-3-METHOXYANILINE(17126-75-9)

Safety Data

• Safety Statements: S24/25:Avoid contact with skin and eyes.
• Hazardous Substances Data: 17126-75-9(Hazardous Substances Data)

Usage

Chemical Properties

white crystalline needles or powder

InChI:InChI=1/C11H17NO3/c1-15-11-4-2-3-10(9-11)12(5-7-13)6-8-14/h2-4,9,13-14H,5-8H2,1H3

Upstream product

• 536-90-3 m-Anisidine 
• 107-07-3 2-chloro-ethanol 
• 75-21-8 oxirane 

Downstream Products

• 6636-74-4 N,N-bis(2-chloroethyl)-3-methoxylaniline 
• 1268821-33-5 4'-(3-methoxyphenyl)spiro[indoline-1,1'-piperazin]-1-ium chloride 
• 1268821-40-4 N,N-bis(2-(methylsulfonyloxy)ethyl)-3-methoxylaniline 
• 1309112-49-9 1,4-dioxa-7,13-dithia-10-(3-methoxyphenyl)-10-azacyclopentadecane 
• 119703-28-5 3-methoxy-bisaniline 

Relevant articles and documents

Synthesis and structure-analgesic activity relationships of a novel series of monospirocyclopiperazinium salts (MSPZ)

A series of monospirocyclopiperazinium salts were designed and synthesized to search for a peripherally-acting analgesic drug with low side effects. Extensive SAR studies revealed that a suitable NR2R3 was critical for the analgesic activity, which might be beneficial to expose the cationic nitrogen to bind to the receptor, and possibly interact with the receptor via π-π interaction. Introduction of substituting group on the N4-phenyl ring could improve the activity, and the best position was the 4-position. Compound 14n showed more potent analgesic activity (63%, 20 μM/kg, sc) and holds promise for development as a mechanically new analgesic drug.

A NEW APPROACH TO THE SYNTHESIS OF ARYLDIFLUOROPHOSHINES. FORMATION OF CIS-DICHLORO-BIS(ARYLDIFLUOROPHOSPHINE)PLATINUM(II) COMPLEXES

Reaction of chlorodifluorophosphine with aryllithium compounds has been found to furnish aryldifluorophosphines.This type of reaction is applicable to any aromatic system for which a regioselective lithiation is possible.The most stable products are those